257 related articles for article (PubMed ID: 16484989)
21. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.
Diefenbach A; Tomasello E; Lucas M; Jamieson AM; Hsia JK; Vivier E; Raulet DH
Nat Immunol; 2002 Dec; 3(12):1142-9. PubMed ID: 12426565
[TBL] [Abstract][Full Text] [Related]
22. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH
Immunity; 2002 Jul; 17(1):19-29. PubMed ID: 12150888
[TBL] [Abstract][Full Text] [Related]
23. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of cell surface Toll-like receptor 4-MD2 expression on dendritic epidermal T cells after the emigration from epidermis during cutaneous inflammation.
Shimura H; Nitahara A; Ito A; Tomiyama K; Ito M; Kawai K
J Dermatol Sci; 2005 Feb; 37(2):101-10. PubMed ID: 15659328
[TBL] [Abstract][Full Text] [Related]
25. Depletion of gammadelta T cells exacerbates murine adriamycin nephropathy.
Wu H; Wang YM; Wang Y; Hu M; Zhang GY; Knight JF; Harris DC; Alexander SI
J Am Soc Nephrol; 2007 Apr; 18(4):1180-9. PubMed ID: 17329577
[TBL] [Abstract][Full Text] [Related]
26. NKG2D ligands: key targets of the immune response.
González S; López-Soto A; Suarez-Alvarez B; López-Vázquez A; López-Larrea C
Trends Immunol; 2008 Aug; 29(8):397-403. PubMed ID: 18602338
[TBL] [Abstract][Full Text] [Related]
27. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.
Malarkannan S; Regunathan J; Chu H; Kutlesa S; Chen Y; Zeng H; Wen R; Wang D
J Immunol; 2007 Sep; 179(6):3752-62. PubMed ID: 17785812
[TBL] [Abstract][Full Text] [Related]
28. Impairment of NK cell function by NKG2D modulation in NOD mice.
Ogasawara K; Hamerman JA; Hsin H; Chikuma S; Bour-Jordan H; Chen T; Pertel T; Carnaud C; Bluestone JA; Lanier LL
Immunity; 2003 Jan; 18(1):41-51. PubMed ID: 12530974
[TBL] [Abstract][Full Text] [Related]
29. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.
Graham DB; Cella M; Giurisato E; Fujikawa K; Miletic AV; Kloeppel T; Brim K; Takai T; Shaw AS; Colonna M; Swat W
J Immunol; 2006 Aug; 177(4):2349-55. PubMed ID: 16887996
[TBL] [Abstract][Full Text] [Related]
30. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.
Zompi S; Hamerman JA; Ogasawara K; Schweighoffer E; Tybulewicz VL; Di Santo JP; Lanier LL; Colucci F
Nat Immunol; 2003 Jun; 4(6):565-72. PubMed ID: 12740576
[TBL] [Abstract][Full Text] [Related]
31. T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells.
Wu J; Groh V; Spies T
J Immunol; 2002 Aug; 169(3):1236-40. PubMed ID: 12133944
[TBL] [Abstract][Full Text] [Related]
32. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
[TBL] [Abstract][Full Text] [Related]
33. Regulation of cutaneous malignancy by gammadelta T cells.
Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
Science; 2001 Oct; 294(5542):605-9. PubMed ID: 11567106
[TBL] [Abstract][Full Text] [Related]
34. NKG2D: A versatile player in the immune system.
Jelenčić V; Lenartić M; Wensveen FM; Polić B
Immunol Lett; 2017 Sep; 189():48-53. PubMed ID: 28414183
[TBL] [Abstract][Full Text] [Related]
35. Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.
Barber A; Zhang T; DeMars LR; Conejo-Garcia J; Roby KF; Sentman CL
Cancer Res; 2007 May; 67(10):5003-8. PubMed ID: 17510432
[TBL] [Abstract][Full Text] [Related]
36. Role for E-cadherin as an inhibitory receptor on epidermal gammadelta T cells.
Uchida Y; Kawai K; Ibusuki A; Kanekura T
J Immunol; 2011 Jun; 186(12):6945-54. PubMed ID: 21562159
[TBL] [Abstract][Full Text] [Related]
37. An activating immunoreceptor complex formed by NKG2D and DAP10.
Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
[TBL] [Abstract][Full Text] [Related]
38. Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
Zhang T; Barber A; Sentman CL
Cancer Res; 2006 Jun; 66(11):5927-33. PubMed ID: 16740733
[TBL] [Abstract][Full Text] [Related]
39. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
40. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
Verneris MR; Karimi M; Baker J; Jayaswal A; Negrin RS
Blood; 2004 Apr; 103(8):3065-72. PubMed ID: 15070686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
